Navigation Links
ConvaTec and HemCon Announce Co-Promotion Agreement
Date:4/15/2009

Medical Innovators Partner to Bring Advanced Wound and Critical Care Products to U.S. Armed Forces

SKILLMAN, N.J., April 15 /PRNewswire/ -- ConvaTec, a world-leading developer and marketer of innovative medical technologies for community and hospital care, announced today it has signed a co-promotion agreement with HemCon Medical Technologies Inc. to market ConvaTec advanced wound and critical care products to the U.S. Armed Forces.

Through the agreement, HemCon, a leading global developer of advanced medical products, is granted sales and marketing rights to leading ConvaTec products, the company's AQUACEL(R) and AQUACEL(R) Ag dressings for managing acute and chronic wounds and its Flexi-Seal(R) Fecal Management System (FMS) for the management of fecal incontinence.

AQUACEL(R) and AQUACEL(R) Ag dressings feature the unique benefits of Hydrofiber(R) Technology. These dressings gel on contact with wound fluid to provide a moist wound healing environment, manage exudate, protect the periwound skin(1) and reduce pain in situ and on removal.(2),(3),(4) In addition, AQUACEL(R) Ag dressing provides the broad-spectrum antimicrobial properties of ionic silver, which kills a broad range of pathogens in the dressing, including methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE) as demonstrated in vitro.(5)

The innovative Flexi-Seal(R) FMS, a temporary containment device for patients with acute fecal incontinence, was designed to safely and effectively divert fecal matter, protect patients' wounds from fecal contamination, and reduce the risk of both skin breakdown and spread of infection, such as Clostridium difficile (C. difficile).

"ConvaTec is proud to be partnering with HemCon to bring our advanced wound and critical care products to the U.S. Armed Forces," commented Michael Steadman, President, Wound Therapeutics a
'/>"/>

SOURCE ConvaTec
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. ConvaTec Launches SUR-FIT Natura(R) Low-Pressure Adaptor
2. ConvaTec Names Presidents of Wound Therapeutics and Ostomy Care Business Units
3. ConvaTec Launches New Lifestyle Magazine for People With an Ostomy
4. ConvaTec Announces Expanded Indications for AQUACEL(R) and AQUACEL(R) Ag Dressings in Management of Surgical Wounds
5. ConvaTec Announces Divestiture of Unomedical Wound Care and Ophthalmics Business
6. ConvaTec Names Paul Moraviec President, Continence and Critical Care Business Unit and ConvaTec EMEA Region
7. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
8. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
9. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
10. HEI, Inc. Announces Sale of RFID Division Assets
11. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/4/2009)...,, Weak Verification and Loosening of Welfare...ment and Incentives ,, WASHINGTON, Nov. 4 /PRN...e House and Senate health care reform bills contai...to prevent millions of illegal aliens from accessi...deration for American Immigration Reform (FAIR). A...
(Date:11/4/2009)...Keeping patients on the heart-lung machine improve...ov. 4 (HealthDay News) -- Longer-term outcomes for..." meaning without the use of a heart-lung machine,...onal procedure, a major study finds. , One year...he off-pump procedure had died, suffered major com...
(Date:11/4/2009)...,, MINNEAPOLIS, Nov. 4 /PRNewswire-FirstCall/ -... leading provider of integrated employee health an...ed financial results for the third quarter ended S...nue of $19.8 million in the third quarter of 2009,...2008 revenue of $18.5 million. Gross profit for th...
(Date:11/4/2009)...,, LINTHICUM, Md., Nov. 4 /PRNewswire-FirstCall...I ) announced its financial results for the third ...us was approximately 2,050. Quarterly Results i...n compared to $21.9 million for the same period la...0 million compared to $1.5 million for the same pe...
(Date:11/4/2009)...The result is overeating, research shows , ...too fast can lead to overeating because gulping do...that trigger the feeling of being full, Greek rese... ate 300 milliliters of ice cream at different rat...ut hormones were measured before and after consump...
Breaking Medicine News(10 mins):Health News:Health Care Reform Legislation Becomes Vehicle for Reshaping Immigration Policy 2Health News:Health Care Reform Legislation Becomes Vehicle for Reshaping Immigration Policy 3Health News:Poorer Outcomes After 'Off-Pump' Bypass Surgery 2Health News:Poorer Outcomes After 'Off-Pump' Bypass Surgery 3Health News:HealthFitness Announces Third Quarter 2009 Financial Results 2Health News:HealthFitness Announces Third Quarter 2009 Financial Results 3Health News:HealthFitness Announces Third Quarter 2009 Financial Results 4Health News:HealthFitness Announces Third Quarter 2009 Financial Results 5Health News:HealthFitness Announces Third Quarter 2009 Financial Results 6Health News:HealthFitness Announces Third Quarter 2009 Financial Results 7Health News:HealthFitness Announces Third Quarter 2009 Financial Results 8Health News:HealthFitness Announces Third Quarter 2009 Financial Results 9Health News:HealthFitness Announces Third Quarter 2009 Financial Results 10Health News:HealthFitness Announces Third Quarter 2009 Financial Results 11Health News:Dialysis Corporation of America Reports Third Quarter 2009 Results 2Health News:Dialysis Corporation of America Reports Third Quarter 2009 Results 3Health News:Dialysis Corporation of America Reports Third Quarter 2009 Results 4Health News:Dialysis Corporation of America Reports Third Quarter 2009 Results 5Health News:Dialysis Corporation of America Reports Third Quarter 2009 Results 6Health News:Dialysis Corporation of America Reports Third Quarter 2009 Results 7Health News:Dialysis Corporation of America Reports Third Quarter 2009 Results 8Health News:Dialysis Corporation of America Reports Third Quarter 2009 Results 9Health News:Fast Eating Limits Gut Hormones That Induce Fullness 2
...ll. Swinging their arms helped participants in a ...swinging strings, researchers report, demonstratin...stand and solve complex problems. , The study, ap...fluenced by how he or she moves. , "Our manipulat...
...May 12 Nonin Medical, Inc., a leading innovator o...and the inventor of the Onyx(R) fingertip pulse ox...l patient monitoring device, the GO2(TM) fingertip...to complement their clinician-advised oxygen thera...
..., N.Y., MAY 11, 2009 Women who take folic acid su... pregnant may cut their risk of having a premature...s week in the online journal, PLoS Medicine . , ... of age, race or other factors. Of particular note...
...al Security Trustees Say Outlook is Bleak, NCPA Sa...are/Social Security Trustees, Annual Report - rele... future for entitlement funding with projected def...perts. , , "The reality is that Medicare and oth...
...ier Quantitative Company and Drug Evaluation Tool ...ilable Now with a New User-Friendly Interface , ,... Data for Over 1000 Drugs Across 147 Product Class...ssues, finds that the growth in drug sales of the ...
...t device that gets kids to want to wash their hand... kids picking up the swine flu virus from not wash... parents who became frustrated that their kids wer...LC, a unique device that gets kids to want to wa...
Other Medicine News:Health News:Body movements can influence problem solving, researchers report 2Health News:Body movements can influence problem solving, researchers report 3Health News:Nonin Medical's GO2(TM) Personal Fingertip Pulse Oximeter Empowers Patients Worldwide 2Health News:Taking folic acid for a year before pregnancy may reduce risk of preterm birth 2Health News:Growth in Drug Sales of the Top 10 Pharmaceutical Companies Slowed to its Lowest Level in Years in 2008 2Health News:Flashing Lights Help Kids Avoid the Swine Flu 2
(Date:11/4/2009)...AKES, N.J., Nov. 4 BD (B...bal medical technology company, announced today th...thcare conferences: , , 2009 Annual Credit ...2009, 11:00 a.m. EST, Piper Jaffray...r 2, 2009, 1:00 p.m. EST, , A live webca...
(Date:11/4/2009)... Calif., Nov. 4 Varian, ...r fiscal year 2009 revenues of $196.5 million, a d... year 2008. Orders exceeded revenues by approxima...ar 2009. ,, Non-GAAP (adjusted) diluted earning....40, a decrease of 48.7% from the $0.78 in the fou...
(Date:11/4/2009)... Nov. 4 New findings presented tod...idate HCl Extended-Release Tablets CII) is the onl...a significant treatment effect on attention at one...ntion Deficit Hyperactivity Disorder (ADHD). ADHD ...terized by inattention, hyperactivity and impulsiv...
Breaking Medicine Technology:Varian, Inc. Reports Fourth Quarter 2009 Results 2Varian, Inc. Reports Fourth Quarter 2009 Results 3Varian, Inc. Reports Fourth Quarter 2009 Results 4Varian, Inc. Reports Fourth Quarter 2009 Results 5Varian, Inc. Reports Fourth Quarter 2009 Results 6Varian, Inc. Reports Fourth Quarter 2009 Results 7Varian, Inc. Reports Fourth Quarter 2009 Results 8Varian, Inc. Reports Fourth Quarter 2009 Results 9Varian, Inc. Reports Fourth Quarter 2009 Results 10Varian, Inc. Reports Fourth Quarter 2009 Results 11Varian, Inc. Reports Fourth Quarter 2009 Results 12Varian, Inc. Reports Fourth Quarter 2009 Results 13Varian, Inc. Reports Fourth Quarter 2009 Results 14Varian, Inc. Reports Fourth Quarter 2009 Results 15Varian, Inc. Reports Fourth Quarter 2009 Results 16Varian, Inc. Reports Fourth Quarter 2009 Results 17Varian, Inc. Reports Fourth Quarter 2009 Results 18Varian, Inc. Reports Fourth Quarter 2009 Results 19Varian, Inc. Reports Fourth Quarter 2009 Results 20Varian, Inc. Reports Fourth Quarter 2009 Results 21Varian, Inc. Reports Fourth Quarter 2009 Results 22CONCERTA(R) in the Classroom: New Data on Attention in Children With ADHD 2CONCERTA(R) in the Classroom: New Data on Attention in Children With ADHD 3CONCERTA(R) in the Classroom: New Data on Attention in Children With ADHD 4CONCERTA(R) in the Classroom: New Data on Attention in Children With ADHD 5CONCERTA(R) in the Classroom: New Data on Attention in Children With ADHD 6CONCERTA(R) in the Classroom: New Data on Attention in Children With ADHD 7Protein that promotes cancer cell growth identified 9345 1Protein that promotes cancer cell growth identified 9345 2Informex Rebrands Into Separate Pharmaceutical and Specialty Chemical Segments to Better Serve Exhibitors and Attendees 13190 1Informex Rebrands Into Separate Pharmaceutical and Specialty Chemical Segments to Better Serve Exhibitors and Attendees 13190 2Informex Rebrands Into Separate Pharmaceutical and Specialty Chemical Segments to Better Serve Exhibitors and Attendees 13190 3Wanted 3A Oklahoma City Licensed Pharmacy Technicians 52670 1Wanted 3A Oklahoma City Licensed Pharmacy Technicians 52670 2
...Inc.,(Nasdaq: ENCO ), a full service multinationa...studies in over 30 countries for many of the world...ies, today announced that at,this time Encorium an...ations regarding Encorium,s planned acquisition of... companies have decided to form a strategic,partne...
...rmaceuticals, Inc. (OTC Bulletin Board: TDLP), a s...ing non-invasive, topically,administered medicatio...ent,in the Phase 3 registration trial for Ketotran...anti-inflammatory topical cream, contains 10%,keto...SAID"), and is,intended for use in the treatment o...
Other Medicine Technology:Encorium Announces the Initiation of a Strategic Partnership With Prologue Research After the Postponement of Negotiations Regarding Its Planned Acquisition; Strategic Reorganization and Cost Reduction Plan Initiated as Strategic Alternatives are Investig 2Encorium Announces the Initiation of a Strategic Partnership With Prologue Research After the Postponement of Negotiations Regarding Its Planned Acquisition; Strategic Reorganization and Cost Reduction Plan Initiated as Strategic Alternatives are Investig 3Encorium Announces the Initiation of a Strategic Partnership With Prologue Research After the Postponement of Negotiations Regarding Its Planned Acquisition; Strategic Reorganization and Cost Reduction Plan Initiated as Strategic Alternatives are Investig 4Transdel Enrolls First Patient for Ketotransdel(TM) Phase 3 Clinical Trial 2Transdel Enrolls First Patient for Ketotransdel(TM) Phase 3 Clinical Trial 3Transdel Enrolls First Patient for Ketotransdel(TM) Phase 3 Clinical Trial 4
...s a dual-sided ePTFE mesh designed for ventral her...e designed to minimize visceral attachment to the ...ructure designed to promote tissue growth. This in...icrons, which is nearly equivalent to polypropylen...
... is the first polypropylene mesh specifically desi...directly addresses the critical issues associated ...t delivers maximum visibility, enhanced maneuverab...hrough the trocar.,Visilex mesh is the culminatio...
...lene mesh is constructed of knitted filaments of e...that used in PROLENE* Polypropylene Suture, Nonabs...The mesh is approximately,0.020 inches thick. This...d to be non-reactive and to retain its strength in...
Surgisis® IHM™ Inguinal Hernia Matrix
Medicine Products: